Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1958 1
1960 1
1963 1
1964 1
1965 2
1970 1
1971 1
1975 1
1977 1
1978 1
1979 3
1980 1
1981 2
1982 2
1983 3
1984 1
1986 5
1987 6
1988 2
1989 5
1990 5
1991 8
1992 12
1993 8
1994 14
1995 9
1996 13
1997 18
1998 23
1999 20
2000 25
2001 15
2002 18
2003 12
2004 20
2005 20
2006 30
2007 17
2008 23
2009 23
2010 28
2011 27
2012 31
2013 41
2014 41
2015 52
2016 55
2017 56
2018 88
2019 76
2020 66
2021 85
2022 70
2023 74
2024 40

Text availability

Article attribute

Article type

Publication date

Search Results

1,077 results

Results by year

Filters applied: . Clear all
Page 1
MYC degradation.
Farrell AS, Sears RC. Farrell AS, et al. Cold Spring Harb Perspect Med. 2014 Mar 1;4(3):a014365. doi: 10.1101/cshperspect.a014365. Cold Spring Harb Perspect Med. 2014. PMID: 24591536 Free PMC article. Review.
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.
Chehade M, Dellon ES, Spergel JM, Collins MH, Rothenberg ME, Pesek RD, Hirano I, Liu R, Laws E, Mortensen E, Martincova R, Shabbir A, McCann E, Kamal MA, Kosloski MP, Hamilton JD, Samuely C, Lim WK, Wipperman MF, Farrell A, Patel N, Yancopoulos GD, Glotfelty L, Maloney J. Chehade M, et al. Among authors: farrell a. N Engl J Med. 2024 Jun 27;390(24):2239-2251. doi: 10.1056/NEJMoa2312282. N Engl J Med. 2024. PMID: 38924731 Clinical Trial.
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. Filipovich AH, et al. Among authors: farrell a. Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56. doi: 10.1016/j.bbmt.2005.09.004. Biol Blood Marrow Transplant. 2005. PMID: 16338616 Free article.
Notable advances 2017.
Bondar T, Carmona J, Gao K, Benedetti B, Basson M, Levinson R, Stower H, Farrell A. Bondar T, et al. Among authors: farrell a. Nat Med. 2017 Dec 7;23(12):1387-1389. doi: 10.1038/nm1217-1387. Nat Med. 2017. PMID: 29216032 No abstract available.
Gemtuzumab ozogamicin.
Przepiorka D, Deisseroth A, Kane R, Kaminskas E, Farrell AT, Pazdur R. Przepiorka D, et al. Among authors: farrell at. J Clin Oncol. 2013 May 1;31(13):1699-700. doi: 10.1200/JCO.2012.48.1887. Epub 2013 Mar 25. J Clin Oncol. 2013. PMID: 23530094 No abstract available.
The effects of stretching on performance.
Peck E, Chomko G, Gaz DV, Farrell AM. Peck E, et al. Among authors: farrell am. Curr Sports Med Rep. 2014 May-Jun;13(3):179-85. doi: 10.1249/JSR.0000000000000052. Curr Sports Med Rep. 2014. PMID: 24819010 Review.
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
Nesic K, Krais JJ, Wang Y, Vandenberg CJ, Patel P, Cai KQ, Kwan T, Lieschke E, Ho GY, Barker HE, Bedo J, Casadei S, Farrell A, Radke M, Shield-Artin K, Penington JS, Geissler F, Kyran E, Betsch R, Xu L, Zhang F, Dobrovic A, Olesen I, Kristeleit R, Oza A, McNeish I, Ratnayake G, Traficante N; Australian Ovarian Cancer Study; DeFazio A, Bowtell DDL, Harding TC, Lin K, Swisher EM, Kondrashova O, Scott CL, Johnson N, Wakefield MJ. Nesic K, et al. Among authors: farrell a. Mol Cancer. 2024 Aug 5;23(1):158. doi: 10.1186/s12943-024-02048-1. Mol Cancer. 2024. PMID: 39103848 Free PMC article.
Full-spike deep mutational scanning helps predict the evolutionary success of SARS-CoV-2 clades.
Dadonaite B, Brown J, McMahon TE, Farrell AG, Asarnow D, Stewart C, Logue J, Murrell B, Chu HY, Veesler D, Bloom JD. Dadonaite B, et al. Among authors: farrell ag. bioRxiv [Preprint]. 2023 Nov 14:2023.11.13.566961. doi: 10.1101/2023.11.13.566961. bioRxiv. 2023. Update in: Nature. 2024 Jul;631(8021):617-626. doi: 10.1038/s41586-024-07636-1. PMID: 38014024 Free PMC article. Updated. Preprint.
1,077 results